Hong Zhang

Hong Zhang, Ph.D, currently serves as the Executive Director of Toxicology and ADC Research at Sorrento Therapeutics, Inc. since January 2021. Prior experience includes the role of Associate Director at Concortis Biosystem Inc., focusing on the development of novel antibody drug conjugates for anti-cancer therapy, and a Sr. Scientist/Project Leader position at Biogen Idec, where efforts centered on evaluating novel targets in cancer metabolism and leading cross-functional teams. Earlier in the career, Hong Zhang contributed to cancer therapy research at Conforma Therapeutics and DuPont Pharmaceuticals, and held postdoctoral fellowships at The Burnham Institute and the University of Pittsburgh School of Medicine. The academic background includes a Ph.D. in Biochemistry from the University of Pittsburgh School of Medicine.